Wearable technology for pregnant women with Type 1 Diabetes

Dawn Adams

Wearable technology for pregnant women with Type 1 Diabetes

Dawn Adams

School of Computing

Research output: Contribution to conference › Poster › peer-review

Abstract

Type 1 Diabetes (T1D) is a chronic auto-immune
condition. Pregnancies in this population are high risk for both mother & baby.
Pregnancy management for women with T1D involves:
Glucose monitoring, 8-12 times daily
Insulin administration, 4-8 times daily
Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios
Participating in regular physical activity (PA).

Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

Original language	English
Pages	1
Number of pages	1
Publication status	Published (in print/issue) - 8 Jun 2021
Event	32nd International Confederation of Midwives Virtual Triennial Congress - Online Duration: 2 Jun 2021 → 30 Jun 2021 https://www.icmvirtualcongress.org/

Conference

Conference	32nd International Confederation of Midwives Virtual Triennial Congress
Abbreviated title	ICM
Period	2/06/21 → 30/06/21
Internet address	https://www.icmvirtualcongress.org/

Keywords

integrating data
wearable technologies
pregnant women
T1D
pregnancy
maternal outcomes
foetal outcomes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

1 Conference contribution

Integrated Care for Pregnant Women with Type One Diabetes using Wearable Technology
Adams, D., Zheng, H., Sinclair, M., Murphy, M. H. & Mc Cullough, J., 18 Nov 2019, BIBE 2019; The Third International Conference on Biological Information and Biomedical Engineering. VDE Verlag, 5 p.
Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Open Access
File

Cite this

@conference{0a332f197fba45d3a0c80f2daf92fddf,

title = "Wearable technology for pregnant women with Type 1 Diabetes",

abstract = "Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother & baby.Pregnancy management for women with T1D involves:Glucose monitoring, 8-12 times dailyInsulin administration, 4-8 times dailyCalculating carbohydrates and matching this to personal insulin/carbohydrate ratiosParticipating in regular physical activity (PA). Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.",

keywords = "integrating data, wearable technologies, pregnant women, T1D, pregnancy, maternal outcomes, foetal outcomes",

author = "Dawn Adams",

year = "2021",

month = jun,

day = "8",

language = "English",

pages = "1",

note = "32nd International Confederation of Midwives Virtual Triennial Congress, ICM ; Conference date: 02-06-2021 Through 30-06-2021",

url = "https://www.icmvirtualcongress.org/",

}

TY - CONF

T1 - Wearable technology for pregnant women with Type 1 Diabetes

AU - Adams, Dawn

PY - 2021/6/8

Y1 - 2021/6/8

N2 - Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother & baby.Pregnancy management for women with T1D involves:Glucose monitoring, 8-12 times dailyInsulin administration, 4-8 times dailyCalculating carbohydrates and matching this to personal insulin/carbohydrate ratiosParticipating in regular physical activity (PA). Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

AB - Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother & baby.Pregnancy management for women with T1D involves:Glucose monitoring, 8-12 times dailyInsulin administration, 4-8 times dailyCalculating carbohydrates and matching this to personal insulin/carbohydrate ratiosParticipating in regular physical activity (PA). Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

KW - integrating data

KW - wearable technologies

KW - pregnant women

KW - T1D

KW - pregnancy

KW - maternal outcomes

KW - foetal outcomes

M3 - Poster

SP - 1

T2 - 32nd International Confederation of Midwives Virtual Triennial Congress

Y2 - 2 June 2021 through 30 June 2021

ER -

Wearable technology for pregnant women with Type 1 Diabetes

Abstract

Conference

Keywords

UN SDGs

Fingerprint

Research output

Integrated Care for Pregnant Women with Type One Diabetes using Wearable Technology

Cite this